340binformed.org

Your Free Source for 340B News and Commentary

  • About us
  • Advertise
  • Contact
  • 340B Health

Bristol-Myers Squibb Ends Bulk Replenishment for Plavix

Widely-used anti-coagulant came off patent on May 17
 

Print Article

June 21, 2012—Bristol-Myers Squibb’s (BMS) patient assistance foundation has notified hospitals that the drug manufacturer’s blockbuster anti-coagulant Plavix is no longer available for bulk replenishment. Plavix also is no longer listed on the foundation’s Web site among the medications available at no cost to low-income and uninsured individuals. 


You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register.    Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

LATEST ARTICLES DELIVERED

Get new article alerts via email.

This field is required.

Check your inbox or spam folder now to confirm your subscription.

FOLLOW | SHARE | LIKE

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

340B Health Twitter

Twitter feed is not available at the moment.

RSS 340B Employed

  • 340B Compliance Auditor | Geisinger April 5, 2026
  • Coordinator Pharmacy 340B Program - General Pharmacy - Full Time | CHRISTUS Health April 5, 2026
  • Pharmacy Business Manager | Nemours Children's Health April 5, 2026
  • Analyst-Financial Senior | Indiana University Health April 4, 2026
  • 340B Director - Milwaukee, WI | Ascension March 24, 2026

Copyright © 2026 · 340B Health